High Grade Gold Discovered at Classic Minerals’ Forrestania Project

|

Published 15-MAY-2018 12:09 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Classic Minerals (ASX:CLZ) this morning announced that its recent RC drilling program has unearthed high grade gold at the Forrestania Gold Project (FGP) in Western Australia.

The company drilled a total of 11 holes for 750m, including two holes for 174m at new prospect Van Uden West, five holes for 366m at Lady Lila, and four holes for 210m at Kat Gap. The aim of the program was to uncover a new gold system (at Van Uden West) and improve/increase the known mineralisation at Lady Lila and Kat Gap.

The project has an existing JORC (2012) Mineral Resource of existing Mineral Resource of 5.3 Mt at 1.39 g/t for 240,000 ounces of gold.

Assays results confirm the compelling new gold discovery and discovery of a significant new zone of gold mineralisation at the project’s Van Uden West prospect. The drilling results included 12m at 5.75 g/t gold from 59m including 1m at 25.60 g/t gold from 59m.

Preliminary interpretation suggests that the prospect is similar in geological characteristics to Kat Gap with gold mineralisation sitting adjacent to the granite/greenstone contact.

Drilling at the Kat Gap tenement delivered significant high-grade results and remains open along strike. Results include 5m at 14.10 g/t gold from 17m including 1m at 48.40 g/t gold from 20m.

Lady Lila drilling returned excellent results too and mineralisation remains open along strike. Results at Lady Lila include 14m at 3.70 g/t gold from 71m, including 1m at 13.20 g/t gold from 79m, and 8m at 3.21 g/t gold from 70m, including 1m at 11.40 g/t gold from 72m.

Here are the program’s drill sites:

Classic minerals forrestania gold project

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

Here are the assay highlights:

Classic minerals tenement breakdown

The maiden drilling program proved to be quite cost effective as it cost CLZ less than $50,000 to drill the 11 holes for 750 metres, and included all assays and related tech work.

CLZ CEO Dean Goodwin said, “First pass regional drilling campaigns don’t get any better than this. We encountered thick, high grade zones of mineralisation at each of the drill targets which all remain open along strike with high priority zones requiring urgent follow up. This is a great position for the company to be in: we don’t know how big these targets are and can’t wait to get stuck back into drilling.

“The campaign absolutely reinforces how good a project the FGP truly is – our first venture beyond the “flagship” deposits of Lady Magdalene and Lady Ada has been incredibly successful, and we look forward to heading into the next phase of the company’s growth and success.

“We should also point out that this drilling program, along with all associated assays and additional technical work cost less than $50,000 AUD. This is a great testament to CLZ’s “new” approach to exploration planning and spending at FGP – we carefully plan all exploration activities and keep a tight control on costs to ensure shareholder funds are wisely spent with the goal of delivering value to all shareholders.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X